Myelination and mTOR

E-ISSN： 1098-1136|66|4|693-707

ISSN： 0894-1491

Source： GLIA, Vol.66, Iss.4, 2018-04, pp. : 693-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Pathways in Cancer and Autophagy

By Paquette Mathieu El-Houjeiri Leeanna Pause Arnim

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

mTOR Pathway – Novel Modulator of Astrocyte Activity

By Latacz Anna Russell John A. Ocłoń Ewa Zubel-Łojek Joanna Pierzchała-Koziec Krystyna

Folia Biologica, Vol. 63, Iss. 2, 2015-04 ,pp. : 95-105

Institute of Systematics and Evolution of Animals, Polish Academy of Sciences

Access to resources Recommend Favorite

Role of mTOR Inhibitors in Kidney Disease

By Kajiwara Moto Masuda Satohiro

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 975-975

MDPI

Access to resources Recommend Favorite

The mTOR Signalling Pathway in Human Cancer

By Pópulo Helena Lopes José Manuel Soares Paula

International Journal of Molecular Sciences, Vol. 13, Iss. 2, 2012-02 ,pp. : 1886-1918

MDPI

Access to resources Recommend Favorite

Expression profiles of mTOR pathway proteins in porocarcinoma: A provisional immunohistochemical study

By Ishida Okabe

Biomedical Reports, Vol. 1, Iss. 1, 2013-01 ,pp. : 28-30

Spandidos Publications

Access to resources Recommend Favorite